Puma Biotechnology Inc
PBYIBiotechnology
$10.54−0.75%As of Oct 29vs prior close
- Market cap
- $544.1M
- P/E (TTM)
- 19.9×
- P/E (FY1)
- 26.1×
- From 52W high
- −6.39%
- EPS (LTM)
- $0.52
- Revenue (LTM)
- $231.2M
- Net margin
- 11.55%
- Dividend yield
- 0.00%
Nomior Score
77
Steady ProfileTop 3% of the scored universe
Growth53
Quality75
Value—
Momentum98
Resilience56
Growth
+30.18%revenue a year over 8 fiscal years
YE17 $27.7MLTM $231.2M
Connections
Revenue to profitQ2 YE26
14% of revenue became net profit, up 3 pts on a year.
Who owns it
2funds